{"id":214932,"date":"2025-03-06T15:18:49","date_gmt":"2025-03-06T15:18:49","guid":{"rendered":"https:\/\/cryptonews.com\/tr\/news\/medical-tech-firm-bionexus-gene-lab-announces-new-ethereum-focused-treasury-strategy\/"},"modified":"2025-03-06T15:18:49","modified_gmt":"2025-03-06T15:18:49","slug":"abdli-dev-sirketten-ethereum-adimi-resmen-onayladi","status":"publish","type":"post","link":"https:\/\/cryptonews.com\/tr\/news\/abdli-dev-sirketten-ethereum-adimi-resmen-onayladi\/","title":{"rendered":"ABD’li Dev \u015eirketten Ethereum Ad\u0131m\u0131! Resmen Onaylad\u0131"},"content":{"rendered":"
\"\"<\/figure>

Sa\u011fl\u0131k teknolojileri \u015firketi BioNexus Gene Lab, Ethereum’u (ETH<\/a>) birincil hazine varl\u0131\u011f\u0131 olarak resmen onaylad\u0131<\/a>. Hazinesine ETH’yi dahil eden ilk Nasdaq \u015firketi olan BioNexus, bu hamleyle birlikte hazine y\u00f6netiminde \u00f6nemli bir de\u011fi\u015fikli\u011fe gitmi\u015f oldu.<\/p>

\u015eirket, y\u00f6netim kurulunun ETH odakl\u0131 hazine stratejisine onay verdi\u011fini s\u00f6yledi. BioNexus Gene Labs, ETH stratejisiyle ilgili detaylar\u0131 payla\u015farak bu yenilik\u00e7i yakla\u015f\u0131m\u0131n\u0131n arkas\u0131ndaki mant\u0131\u011f\u0131 a\u00e7\u0131klad\u0131.<\/p>

\u015eirketin CEO’su Sam Tan, Ethereum’un di\u011fer dijital varl\u0131klara k\u0131yasla y\u00fcksek likiditesi, kullan\u0131\u015fl\u0131l\u0131\u011f\u0131n ve istikrar\u0131n\u0131n \u00f6ne \u00e7\u0131kt\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>

CEO, “BioNexus Gene Lab Corp., hazinesine Ethereum’u entegre ederek finansal altyap\u0131n\u0131n gelece\u011fini kucakl\u0131yor” dedi.<\/p>

\u015eirketin Ethereum Stratejisi<\/span><\/h2><\/span>

BioNexus, Ethereum stratejisine ili\u015fkin detaylar\u0131 payla\u015ft\u0131. Bunlar aras\u0131nda kripto entegrasyonunun i\u015flem maliyetlerini nas\u0131l azaltaca\u011f\u0131 ve yat\u0131r\u0131m getirilerini nas\u0131l art\u0131raca\u011f\u0131 yer al\u0131yor.<\/p>

\u015eirketin payla\u015ft\u0131\u011f\u0131 belgede<\/a> Ethereum’un stablecoin \u00f6demelerindeki ve merkezi olmayan finans (DeFi) alan\u0131ndaki rol\u00fcn\u00fcn yan\u0131 s\u0131ra uzun vadeli kurumsal hazine varl\u0131\u011f\u0131 olarak potansiyeline dikkat \u00e7ekildi.<\/p>

\n

The board of directors of medical technology company BioNexus Gene Lab has approved a treasury strategy centered on Ethereum (ETH), claiming to be the first Nasdaq-listed company focused on Ethereum. https:\/\/t.co\/1i1EfRYfUA<\/a><\/p>— Wu Blockchain (@WuBlockchain) March 6, 2025<\/a><\/blockquote>